MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$2,787K
Short-term marketable
securities
$84,197K
Cash and cash
equivalents
$32,496K
Operating lease
right-of-use assets
$115K
Long-term marketable
securities
$8,806K
Total current assets
$119,480K
Total assets
$128,401K
Total liabilities and
stockholders' equity
$128,401K
Total stockholders'
equity
$119,255K
Total current
liabilities
$9,146K
Accumulated deficit
-$336,781K
Accumulated other
comprehensive income
$117K
Additional paid-in capital
$455,916K
Operating lease
liabilities
$115K
Accrued expenses and
other current...
$4,788K
Accounts payable
$4,243K
Common stock-Common
Class A
$3K
Back
Back
Balance Sheet
source: myfinsight.com
Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc. (SGMT)